Similar Papers

Paper Title
Journal
Date
Author
The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review.
Mohammad Amin Habibi ... Mohadeseh Zahedi
Biology | VOL. 11
Mohammad Amin Habibi, et. al.Mohammad Amin Habibi ... Mohadeseh Zahedi
06 Dec 2022
In Reply to ‘Rituximab and B-Cell Return in ANCA-Associated Vasculitis’
Cees G.M Kallenberg ... Peter Heeringa
American Journal of Kidney Diseases | VOL. 63
Cees G.M Kallenberg, et. al.Cees G.M Kallenberg ... Peter Heeringa
21 May 2014
Safety and Efficacy Of Rituximab In adult's Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospective French ITP-Ritux Registry
Mehdi Khellaf ...
Blood | VOL. 122
Mehdi Khellaf, et. al.Mehdi Khellaf ...
15 Nov 2013
Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis—a case series
A Knight ... E Baecklund
Clinical Rheumatology | VOL. 33
A Knight, et. al.A Knight ... E Baecklund
20 Aug 2013
View more papers

More From: Rheumatology

Paper Title
Journal
Date
Author
Nomogram for predicting proliferative lupus nephritis in patients with low-level proteinuria
Yuewen Lu ... Wei Chen
Rheumatology | VOL. -
Yuewen Lu, et. al.Yuewen Lu ... Wei Chen
16 Jan 2025
Comment on: Caffeine improves systemic lupus erythematosus endothelial dysfunction by promoting endothelial progenitor cells survival: Reply
Valeria Orefice ... Fabrizio Conti
Rheumatology | VOL. -
Valeria Orefice, et. al.Valeria Orefice ... Fabrizio Conti
15 Jan 2025
Anakinra improves retention rate of targeted treatments in Erdheim-Chester disease
Corrado Campochiaro ... Lorenzo Dagna
Rheumatology | VOL. -
Corrado Campochiaro, et. al.Corrado Campochiaro ... Lorenzo Dagna
15 Jan 2025
Correction to: Efficacy and safety of repository corticotropin injection for refractory cutaneous dermatomyositis: a prospective, open-label study
-
Rheumatology | VOL. -
--
06 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.